SEC Form 4 · accession 0001596771-18-000024
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey G Park
Officer — Interim CEO · Director
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2018 | A | 69,349 | $0.00 | A | 76,989 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 4, 2018, the reporting person received a grant of restricted stock with a total value of $1,000,000 (approximately 48,146 shares of restricted stock based on the Company's closing stock price on the NYSE on the grant date) vesting in four equal installments. In connection with the Board's refinement of the reporting person's compensation package as Interim CEO, the reporting person's foregoing grant of restricted stock was subsequently cancelled on February 26, 2018. In lieu of the prior award, the reporting person received a grant of 69,349 restricted stock units ("RSUs") on February 26, 2018. 9,166 of these RSUs vested on the grant date and 60,183 of these RSUs will vest in five equal monthly installments on the fourth day of each month between March and July 2018.